Novo Nordisk's Wegovy Gets U.S. Approval for Liver Disease, Sam Altman Warns of AI Bubble

The Rundown
18/08/2025 9 min

Listen "Novo Nordisk's Wegovy Gets U.S. Approval for Liver Disease, Sam Altman Warns of AI Bubble"

Descargar episodio Ver en sitio original

Episode Synopsis

Stock Market update for August 18, 2025. This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Public.com/disclosures⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

More episodes of the podcast The Rundown

Meta Hires Apple Design Chief, Sam Altman Explores a SpaceX Rival 04/12/2025
Anthropic Eyes 2026 IPO, Amazon Launches New AI Chip 03/12/2025
OpenAI Declares Code Red, Apple’s AI Chief Steps Down 02/12/2025
Tesla's European Sales Nosedive in November, Nvidia Invests $2B into Synopsys 01/12/2025
Nvidia vs. Google: Is the AI Chip Race Winner Take All? 30/11/2025
Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company 29/11/2025
Black Friday Sales to Top 2024, Baidu Aims to Be China's New AI Chip King 28/11/2025
OpenAI Needs to Raise $207B by 2030, Klarna Launches New Stablecoin 26/11/2025
Meta in Talks to Spend Billions on Google's TPU Chips, Trump Signs Order for AI 'Manhattan Project' 25/11/2025
U.S. Senators Raise Alarm on Meta's Spam Ads, iPhone Air Sales Dissapoint 24/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA